Hemodynamic correlates of exercise function in patients with primary pulmonary hypertension

Division of Pediatric Cardiology, Babies Hospital, Columbia-Presbyterian Medical Center, New York, New York.

The purpose of this investigation was to study the hemodynamic correlates of exercise function in patients with primary pulmonary hypertension and to further define the role of exercise testing in the evaluation of these individuals. Data from the progressive exercise tests and subsequent cardiac catheterization in 16 consecutive patients, aged 16.9 +/- 10.4 years (range 6 to 35), with primary pulmonary hypertension were prospectively collected and analyzed. Exercise capacity averaged 40 +/- 36% (range 0 to 117%) of that predicted for age, height and gender. Statistically significant correlations existed between exercise capacity and 10 invasively measured hemodynamic variables. Mean right atrial pressure, a variable previously noted to be one of the best predictors of survival in patients with primary pulmonary hypertension, correlated best with exercise capacity (r = -0.83, p less than 0.0001). Exercise capacity greater than 75% of the predicted value identified the two patients who had a positive response to acute pulmonary vasodilator drug testing. Poor exercise capacity (less than 10% of the predicted value) identified the three patients who died during or soon after cardiac catheterization. The ability of exercise testing to identify patients at high risk for cardiac catheterization was superior to that of other noninvasive variables. Results of exercise testing may help guide decisions regarding the optimal timing of heart-lung or single lung transplantation.

This article has been cited by other articles:

				S. Bokhari, A. Raina, E. Berman Rosenweig, P. C. Schulze, J. Bokhari, A. J. Einstein, R. J. Barst, and L. L. Johnson PET Imaging May Provide a Novel Biomarker and Understanding of Right Ventricular Dysfunction in Patients With Idiopathic Pulmonary Arterial Hypertension Circ Cardiovasc Imaging, November 1, 2011; 4(6): 641 - 647. [Abstract] [Full Text] [PDF]

				C. E. Ventetuolo, R. L. Benza, A. J. Peacock, R. T. Zamanian, D. B. Badesch, and S. M. Kawut Surrogate and Combined End Points in Pulmonary Arterial Hypertension Proceedings of the ATS, July 15, 2008; 5(5): 617 - 622. [Abstract] [Full Text] [PDF]

				R. Naeije Breathing more with weaker respiratory muscles in pulmonary arterial hypertension Eur. Respir. J., January 1, 2005; 25(1): 6 - 8. [Full Text] [PDF]

				G. Deboeck, G. Niset, M. Lamotte, J-L. Vachiery, and R. Naeije Exercise testing in pulmonary arterial hypertension and in chronic heart failure Eur. Respir. J., May 1, 2004; 23(5): 747 - 751. [Abstract] [Full Text] [PDF]

				K. B. Highland, C. Strange, J. Mazur, and K. N. Simpson Treatment of Pulmonary Arterial Hypertension: A Preliminary Decision Analysis Chest, December 1, 2003; 124(6): 2087 - 2092. [Abstract] [Full Text] [PDF]

				R. Budhiraja and P. M. Hassoun Portopulmonary Hypertension: A Tale of Two Circulations Chest, February 1, 2003; 123(2): 562 - 576. [Abstract] [Full Text] [PDF]

				ATS/ACCP Statement on Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277. [Full Text] [PDF]

				D. Chemla, V. Castelain, P. Herve, Y. Lecarpentier, and S. Brimioulle Haemodynamic evaluation of pulmonary hypertension Eur. Respir. J., November 1, 2002; 20(5): 1314 - 1331. [Abstract] [Full Text] [PDF]

				X.-G. Sun, J. E. Hansen, R. J. Oudiz, and K. Wasserman Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension Circulation, July 24, 2001; 104(4): 429 - 435. [Abstract] [Full Text] [PDF]

				H. Ting, X.-G. Sun, M.-L. Chuang, D. A. Lewis, J. E. Hansen, and K. Wasserman A Noninvasive Assessment of Pulmonary Perfusion Abnormality in Patients With Primary Pulmonary Hypertension Chest, March 1, 2001; 119(3): 824 - 832. [Abstract] [Full Text] [PDF]

				S. MIYAMOTO, N. NAGAYA, T. SATOH, S. KYOTANI, F. SAKAMAKI, M. FUJITA, N. NAKANISHI, and K. MIYATAKE Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension: Comparison with Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 487 - 492. [Abstract] [Full Text] [PDF]

				R. J. Barst Do No Harm Chest, November 1, 1999; 116(5): 1147 - 1148. [Full Text] [PDF]

				D. Wax, R. Garofano, and R. J. Barst Effects of Long-term Infusion of Prostacyclin on Exercise Performance in Patients With Primary Pulmonary Hypertension Chest, October 1, 1999; 116(4): 914 - 920. [Abstract] [Full Text] [PDF]

				S. G Haworth Primary pulmonary hypertension in childhood Arch. Dis. Child., November 1, 1998; 79(5): 452 - 455. [Full Text]